Rare diseases
Investigational molecules
Locations
Seidenstrasse 2, 8853
Octapharma AG focuses on clinical research in haematology with a strong emphasis on disorders affecting blood clotting and anticoagulant management. Its studies address conditions linked to impaired coagulation control in surgical, emergency, and perioperative settings.
The sponsor’s research activity includes both acquired and congenital antithrombin deficiency, reflecting interest in restoring anticoagulant balance during surgery and parturition.
Octapharma AG runs clinical trials in conditions such as Factor VIII deficiency, Acquired antithrombin III deficiency, Heparin resistance, Antithrombin III deficiency, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Austria
Croatia
FinlandAustriaAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
